We Started Because the Label Was Wrong

Not wrong in the sense of illegal. Wrong in the sense that mattered less to the people who wrote it. An ingredient list that named the right compounds, at doses too small to have ever been tested on anyone. A 'clinically studied' claim resting on a study that used four times the amount actually in the jar.

This isn't rare. It's the default. Most supplements are formulated by a marketing brief, then dosed to hit a price point — not the other way around.

PONS was built by people who read the studies for a living: a physician and a pharmaceutical chemist, working from the same standard they'd apply to anything meant to go in a body. If a dose in a published trial produced a measured effect, that's the dose we use. If it didn't, the ingredient doesn't make the cut — no matter how well it photographs on a label.

What we believe

Decoration is not formulation.

A long ingredient list is easy. A correct one is not. We'd rather ship four ingredients at the right dose than fourteen at a fraction of it.

Privacy is not secrecy.

We don't publish your data, your order, or your reasons for either. We do publish our dosing, our sourcing, and our batch results - the two are not in tension.

Premium is a standard, not a price.

The cost of doing this properly - trial-matched doses, third-party testing, small batches - shows up in the jar, not in the marketing around it.

We're not asking you to trust a face on this page. We're asking you to check our work - every dose, every source, every batch is published where you can read it. Most brands hope you won't look. We're building the kind that wants you to.